论文部分内容阅读
对１５７例肺心病患者进行血浆中分子物质（ＭＭＳ）含量测定的结果表明，单纯肺心病呼吸衰竭和（或）心力衰竭病人较健康人血浆ＭＭＳ含量增高，肺心病合并多脏器衰竭（ＭＯＦ）病人较单纯肺心病呼吸衰竭和（或）心力衰竭病人血浆ＭＭＳ含量显著增高，并且衰竭脏器数越多，血浆ＭＭＳ含量越高，死亡率越高。因此，对血浆ＭＭＳ含量及变化进行监测，有可能是判断肺心病严重程度和预后的重要指标。
The results of determination of plasma MMS in 157 cases of patients with pulmonary heart disease showed that plasma concentrations of MMS in patients with simple pulmonary heart disease respiratory failure and / or heart failure were higher than those in healthy people, and pulmonary heart disease complicated with multiple organ failure (MOF) Patients with simple pulmonary heart disease respiratory failure and / or heart failure patients with plasma MMS content was significantly higher, and the more the number of organ failure, the higher the plasma MMS content, the higher the mortality rate. Therefore, the monitoring of plasma MMS content and changes may be to determine the severity of pulmonary heart disease and prognosis of an important indicator.